Abstract
It stands to reason that a fetus, as it nears completion, needs a passage to the outer world that is commensurate with its size exactly at the time of parturition. The discrepancy between the pelvic canal and the fetus in most mammals is so large and the pelvis so rigid that a special mechanism must exist which corrects this discrepancy if a species is to persist. Here is one of the few examples where biology has to submit to reason. The birth canal cannot be opened during gestation because of the danger of premature fetal loss, and at the end of gestation the opening of the canal must be coordinated with a dramatic over-all shift of the endocrine balance which causes potentially damaging uterine contractions. This set of circumstances is well known to endocrinologists and explains Hisaw’s experiments with pregnant guinea pig serum. Only a hormone could cause such a change, and most hormones travel from the gland of origin to the site of action by the blood stream. Serum from pregnant animals with relaxed symphyseal joints was a plausible place to search for this factor. Once virgin guinea pigs had been treated with estrogen they responded to the pregnancy serum by significant widening of the symphysis pubis.1 This was a momentous discovery albeit overshadowed by the discovery of insulin, the pancreatic disulfide homologue of relaxin, at about the same time. Insulin took center stage at once because it saved lives and relaxin fell by the wayside because humans had developed a surgical procedure to overcome the problems of pelvic insufficiency. Nonetheless, relaxin researchers had an inkling that insulin and relaxin had something in common (Fig. 2.1). A condensed pictorial summary of both factors as they evolved through their stages of discovery is shown in Figure 2.2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hisaw FL. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 1926; 23: 661–663.
Casten GG, Boucek RJ. Use of relaxin in the treatment of scleroderma. J Am Med Assoc 1958; 166: 319–324.
Sherwood OD, O’Byrne EM. Purification and characterization of porcine relaxin. Arch Biochem Biophys 1974; 160: 185–196.
Schwabe C, McDonald JK, Steinetz BG. Primary structure of the A chain of porcine relaxin. Biochem Biophys Res Commun 1976; 70: 397–405.
Schwabe C, McDonald JK, Steinetz BG. Primary structure of the B-chain of porcine relaxin. Biochem Biophys Res Commun 1977; 75: 503–510.
Büllesbach EE, Schwabe C. On the receptor-binding site of relaxin. Int J Peptide Protein Res 1988; 32: 361–367.
Büllesbach EE, Yang S, Schwabe C. The receptor-binding site of human relaxin II: A dual prong-binding mechanism. J Biol Chem 1992; 267: 22957–22960.
Büllesbach EE, Steinetz BG, Schwabe C. Chemical synthesis of a Zwitterhormon, insulaxin, and of a relaxin-like bombyxin derivative. Biochemistry 1996; 35: 9754–9760.
Schwabe C, LeRoith D, Thompson RP et al. Relaxin extracted from protozoa (Tetrahymena pyriformis). J Biol Chem 1983; 258: 2778–2781.
Ishizaki H, Suzuki A. An insect brain peptide as a member of the insulin family. Horm Metabol Res 1988; 20: 426–429.
Geraerts WPM, Smit AB, Li KW et al. The light green cells of lymnaea: a neuroendocrine model system for stimulus-induced expression of multiple peptide genes in a single cell type. Experientia 1992; 48: 464–473.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, C., Büllesbach, E.E. (1998). A Very Brief History. In: Relaxin and the Fine Structure of Proteins. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12909-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-12909-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-12911-1
Online ISBN: 978-3-662-12909-8
eBook Packages: Springer Book Archive